The profile of autoimmunity in Type 1 diabetes patients

被引:6
|
作者
Derrou, Sara [1 ,2 ]
El Guendouz, Faycal [1 ,2 ]
Benabdelfedil, Yousra [1 ,2 ]
Chakri, Imad [3 ]
Ouleghzal, Hassan [1 ,2 ]
Safi, Somaya [1 ,2 ]
机构
[1] Mil Hosp Moulay Ismail, Dept Endocrinol Diabetol & Nutr, Meknes, Morocco
[2] Univ Sidi Mohamed Ben Abdellah, Fac Med & Pharm, Fes, Morocco
[3] Univ Sidi Mohamed Ben Abdellah, Fac Med & Pharm, Dept Clin Res & Community Hlth Lab, Fes, Morocco
关键词
Autoimmunity; celiac disease; thyroiditis; type; 1; diabetes; CELIAC-DISEASE; THYROID AUTOIMMUNITY; CLINICAL PROFILE; IMMUNE-RESPONSE; CHILDREN; ADOLESCENTS; PREVALENCE; MELLITUS; AUTOANTIBODIES; CELL;
D O I
10.4103/aam.aam_8_20
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Type 1 diabetes mellitus (T1DM) is an autoimmune disorder caused by pancreatic beta-cells destruction. Anti-pancreatic antibodies are the witness of beta-cell destruction and their dosage is mainly used for etiological diagnosis. Patients with T1DM are at increased risk of developing other autoimmune reactions, which may involve other organs, resulting in organ specific autoimmune disease. The most frequently encountered are autoimmune thyroid disease, followed by celiac and gastric disease and other rare autoimmune diseases. Objectives: The purpose of this study is to investigate the prevalence of autoimmune markers in patients with T1DM. Methods: The study was conducted at the Department of Endocrinology of the Military Hospital Moulay Ismail in Meknes Morocco, from January 2016 to December 2018. All Type 1 diabetes patients consulting during the study period were included in the study. Their clinical and biochemical data were collected at their first presentation, made up of anti-pancreatic antibodies (glutamic acid decarboxylase [GAD] antibody, tyrosine phosphatase antibody, and islet cell antibody) and other organ-specific antibodies: the thyroid (antithyroid peroxidase antibody, antithyroglobulin antibody, and antithyroid-stimulating hormone receptor antibody), the intestine (IgA antitissue transglutaminase antibody), the adrenal gland (anti-21 hydroxylase antibody), and the stomach (antigastric parietal cell antibody and anti-intrinsic factor antibody). Results: Fifty-four patients were included, with an average age of 26 years. GAD, tyrosine phosphatase, and islet cell antibodies were detected in 74%, 22%, and 3.7%, respectively, of the 54 patients examined. The prevalence of extrapancreatic autoimmunity was 45% with a large preponderance among different immunities of those from thyroid and celiac diseases (CDs). Conclusion: Our results confirm that patients with Type 1 diabetes should be investigated for the presence of autoimmune diseases mainly from thyroid and CDs.
引用
收藏
页码:19 / 23
页数:5
相关论文
共 50 条
  • [1] Thyroid Autoimmunity in Patients with Type 1 Diabetes
    Monteiro, Ana Margarida
    Coelho, Claudia Matta
    Garcia, Fernando Mota
    [J]. REVISTA PORTUGUESA DE ENDOCRINOLOGIA DIABETES E METABOLISMO, 2019, 14 (01) : 22 - 26
  • [2] The oxylipin profile is associated with development of type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY)
    Buckner, Teresa
    Vanderlinden, Lauren A.
    DeFelice, Brian C.
    Carry, Patrick M.
    Kechris, Katerina
    Dong, Fran
    Fiehn, Oliver
    Frohnert, Brigitte I.
    Clare-Salzler, Michael
    Rewers, Marian
    Norris, Jill M.
    [J]. DIABETOLOGIA, 2021, 64 (08) : 1785 - 1794
  • [3] The oxylipin profile is associated with development of type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY)
    Teresa Buckner
    Lauren A. Vanderlinden
    Brian C. DeFelice
    Patrick M. Carry
    Katerina Kechris
    Fran Dong
    Oliver Fiehn
    Brigitte I. Frohnert
    Michael Clare-Salzler
    Marian Rewers
    Jill M. Norris
    [J]. Diabetologia, 2021, 64 : 1785 - 1794
  • [4] Autoimmunity to tissue tranglutaminase C in patients with type 1 diabetes
    Bonfanti, R
    Bazzigaluppi, E
    Lampasona, V
    Meschi, F
    Bognetti, E
    Bosi, E
    Chiumello, G
    Bonifacio, E
    [J]. DIABETOLOGIA, 1999, 42 : A98 - A98
  • [5] 'Sensing' autoimmunity in type 1 diabetes
    Tsui, Hubert
    Razavi, Rozita
    Chan, Yin
    Yantha, Jason
    Dosch, H-Michael
    [J]. TRENDS IN MOLECULAR MEDICINE, 2007, 13 (10) : 405 - 413
  • [6] Type 1 diabetes associated autoimmunity
    Kahaly, George J.
    Hansen, Martin P.
    [J]. AUTOIMMUNITY REVIEWS, 2016, 15 (07) : 644 - 648
  • [7] Autoimmunity and the pathogenesis of type 1 diabetes
    Csorba, Thomas R.
    Lyon, Andrew W.
    Hollenberg, Morley D.
    [J]. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2010, 47 (02) : 51 - 71
  • [8] Thyroid function and thyroid autoimmunity in patients with type 1 diabetes mellitus
    Radaideh, A
    El-Khateeb, M
    Batieha, AM
    Nasser, AS
    Ajlouni, KM
    [J]. SAUDI MEDICAL JOURNAL, 2003, 24 (04) : 352 - 355
  • [9] Inflammatory profile in patients with type 1 diabetes: exploring a hidden side of type 1 diabetes
    Ruiz de Adana, M. S.
    Rubio-Martin, E.
    Colomo, N.
    Carreira, M.
    Anarte, M. T.
    Maymo-Masip, E.
    Rodriguez-Chacon, M.
    Rojo-Martinez, G.
    [J]. DIABETOLOGIA, 2014, 57 : S185 - S185
  • [10] Autoimmunity as an etiology of fulminant type 1 diabetes
    Shimada, Akira
    [J]. DIABETOLOGY INTERNATIONAL, 2016, 7 (02) : 104 - 105